Since the early 1960s, five-year survival rates for many blood cancer patients have doubled, tripled or even quadrupled. And many LLS supported therapies not only help blood cancer patients but are helping patients with other cancers and serious diseases. In fact, drugs first approved for blood cancers are now approved to treat patients with stomach cancers, skin cancers, and autoimmune diseases like rheumatoid arthritis.
Please consider donating to this worthy cause.
